Birk Achenbach, Pravesh Tamang, Steven Leonhardt, Günter E. M. Tovar, Susanne Zibek
{"title":"Controlled Feeding Facilitates the Development of a Robust Production Process for Terpolymeric Polyhydroxyalkanoates","authors":"Birk Achenbach, Pravesh Tamang, Steven Leonhardt, Günter E. M. Tovar, Susanne Zibek","doi":"10.1002/biot.70252","DOIUrl":null,"url":null,"abstract":"<p>Polyhydroxyalkanoates (PHAs) are a promising class of biodegradable and sustainable biopolymers. However, the current use of PHA is limited by its restricted availability, which is deplorable, as novel PHA variants such as copolymers or terpolymers could offer improved material properties. In this study, we report the production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-4-hydroxyvalerate) (PHBVV) terpolymer with high 3-hydroxyvalerate (3HV) content using <i>Cupriavidus necator</i>. A fully controlled feeding strategy, based on the pH- and pO<sub>2</sub>-signal, was successfully implemented and validated in 7.5 and 42-L bioreactors, enabling controlled delivery of the growth-inhibiting substrate levulinic acid. A maximum biomass of 40.2 ± 0.9 g L<sup>−</sup><sup>1</sup> with 75% CDW PHA was obtained, corresponding to a yield of 0.32 ± 0.02 g<sub>PHA</sub> g<sub>LA</sub><sup>−</sup><sup>1</sup>. Importantly, the process enabled the production of PHBVV with a high 3HV content of 38%–46% and a 4HV content of 1%–2% at both production scales. Beyond demonstrating scalable PHBVV production in stirred tank bioreactors, this work provides a comprehensive comparative dataset, including specific growth rates, substrate uptake rates, yield coefficients, and respiratory activity. The findings presented here constitute both a methodological framework for scaling and process automation of PHBVV production and a valuable reference for the future optimization of PHA bioprocesses.</p>","PeriodicalId":134,"journal":{"name":"Biotechnology Journal","volume":"21 6","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2026-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/biot.70252","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Journal","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/biot.70252","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
Abstract
Polyhydroxyalkanoates (PHAs) are a promising class of biodegradable and sustainable biopolymers. However, the current use of PHA is limited by its restricted availability, which is deplorable, as novel PHA variants such as copolymers or terpolymers could offer improved material properties. In this study, we report the production of poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-4-hydroxyvalerate) (PHBVV) terpolymer with high 3-hydroxyvalerate (3HV) content using Cupriavidus necator. A fully controlled feeding strategy, based on the pH- and pO2-signal, was successfully implemented and validated in 7.5 and 42-L bioreactors, enabling controlled delivery of the growth-inhibiting substrate levulinic acid. A maximum biomass of 40.2 ± 0.9 g L−1 with 75% CDW PHA was obtained, corresponding to a yield of 0.32 ± 0.02 gPHA gLA−1. Importantly, the process enabled the production of PHBVV with a high 3HV content of 38%–46% and a 4HV content of 1%–2% at both production scales. Beyond demonstrating scalable PHBVV production in stirred tank bioreactors, this work provides a comprehensive comparative dataset, including specific growth rates, substrate uptake rates, yield coefficients, and respiratory activity. The findings presented here constitute both a methodological framework for scaling and process automation of PHBVV production and a valuable reference for the future optimization of PHA bioprocesses.
Biotechnology JournalBiochemistry, Genetics and Molecular Biology-Molecular Medicine
CiteScore
8.90
自引率
2.10%
发文量
123
审稿时长
1.5 months
期刊介绍:
Biotechnology Journal (2019 Journal Citation Reports: 3.543) is fully comprehensive in its scope and publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Some issues are devoted to a special topic, providing the latest information on the most crucial areas of research and technological advances.
In addition to these special issues, the journal welcomes unsolicited submissions for primary research articles, such as Research Articles, Rapid Communications and Biotech Methods. BTJ also welcomes proposals of Review Articles - please send in a brief outline of the article and the senior author''s CV to the editorial office.
BTJ promotes a special emphasis on:
Systems Biotechnology
Synthetic Biology and Metabolic Engineering
Nanobiotechnology and Biomaterials
Tissue engineering, Regenerative Medicine and Stem cells
Gene Editing, Gene therapy and Immunotherapy
Omics technologies
Industrial Biotechnology, Biopharmaceuticals and Biocatalysis
Bioprocess engineering and Downstream processing
Plant Biotechnology
Biosafety, Biotech Ethics, Science Communication
Methods and Advances.